Dr. Emily Hébert, a post-doctoral fellow at the Stephenson Cancer Center at OU Medicine, has received a highly competitive federal grant that will launch her research career focused on using mobile technology for tobacco cessation.
Katherine Moxley, M.D., a gynecologic oncologist at the Stephenson Cancer Center at OU Medicine, is one of only 10 physician-scientists nationwide to receive a leadership award from the National Cancer Institute.
Physician-scientists at the Stephenson Cancer Center at OU Medicine recently gave 30 presentations about their cutting-edge cancer research at the annual meeting of the American Society of Clinical Oncology, the largest oncology meeting in the world.
Women with ovarian cancer who have undergone four or more rounds of chemotherapy typically haven’t had much hope that another treatment option will lengthen their lives in a meaningful way. However, a new research study shows tremendous promise for a drug called niraparib to extend life when all options have been exhausted.